Global Female Health Market Research Report 2023

October 2023 | 92 pages | ID: G8C2ADB423BDEN
QYResearch

Abstracts

This report aims to provide a comprehensive presentation of the global market for Female Health, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Female Health.

The Female Health market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Female Health market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Female Health companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

By Company

• Veru Inc.
• Allergan
• Bayer AG
• Merck
• Pfizer
• Teva Pharmaceuticals
• Agile Therapeutics
• Amgen, Inc.
• AstraZeneca
• Bristol-Myers Squibb

Segment by Type

• Medicines
• Treatment
• Other

Segment by Application

• Postmenopausal Osteoporosis
• Infertility
• Endometriosis
• PCOS
• Other

By Region

• North America
• United States
• Canada
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Nordic Countries
• Rest of Europe
• Asia-Pacific
• China
• Japan
• South Korea
• Southeast Asia
• India
• Australia
• Rest of Asia
• Latin America
• Mexico
• Brazil
• Rest of Latin America
• Middle East & Africa
• Turkey
• Saudi Arabia
• UAE
• Rest of MEA

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Female Health companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 12: The main points and conclusions of the report.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Market Analysis by Type
  1.2.1 Global Female Health Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
  1.2.2 Medicines
  1.2.3 Treatment
  1.2.4 Other
1.3 Market by Application
  1.3.1 Global Female Health Market Growth by Application: 2018 VS 2022 VS 2029
  1.3.2 Postmenopausal Osteoporosis
  1.3.3 Infertility
  1.3.4 Endometriosis
  1.3.5 PCOS
  1.3.6 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered

2 GLOBAL GROWTH TRENDS

2.1 Global Female Health Market Perspective (2018-2029)
2.2 Female Health Growth Trends by Region
  2.2.1 Global Female Health Market Size by Region: 2018 VS 2022 VS 2029
  2.2.2 Female Health Historic Market Size by Region (2018-2023)
  2.2.3 Female Health Forecasted Market Size by Region (2024-2029)
2.3 Female Health Market Dynamics
  2.3.1 Female Health Industry Trends
  2.3.2 Female Health Market Drivers
  2.3.3 Female Health Market Challenges
  2.3.4 Female Health Market Restraints

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Female Health Players by Revenue
  3.1.1 Global Top Female Health Players by Revenue (2018-2023)
  3.1.2 Global Female Health Revenue Market Share by Players (2018-2023)
3.2 Global Female Health Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Female Health Revenue
3.4 Global Female Health Market Concentration Ratio
  3.4.1 Global Female Health Market Concentration Ratio (CR5 and HHI)
  3.4.2 Global Top 10 and Top 5 Companies by Female Health Revenue in 2022
3.5 Female Health Key Players Head office and Area Served
3.6 Key Players Female Health Product Solution and Service
3.7 Date of Enter into Female Health Market
3.8 Mergers & Acquisitions, Expansion Plans

4 FEMALE HEALTH BREAKDOWN DATA BY TYPE

4.1 Global Female Health Historic Market Size by Type (2018-2023)
4.2 Global Female Health Forecasted Market Size by Type (2024-2029)

5 FEMALE HEALTH BREAKDOWN DATA BY APPLICATION

5.1 Global Female Health Historic Market Size by Application (2018-2023)
5.2 Global Female Health Forecasted Market Size by Application (2024-2029)

6 NORTH AMERICA

6.1 North America Female Health Market Size (2018-2029)
6.2 North America Female Health Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Female Health Market Size by Country (2018-2023)
6.4 North America Female Health Market Size by Country (2024-2029)
6.5 United States
6.6 Canada

7 EUROPE

7.1 Europe Female Health Market Size (2018-2029)
7.2 Europe Female Health Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Female Health Market Size by Country (2018-2023)
7.4 Europe Female Health Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries

8 ASIA-PACIFIC

8.1 Asia-Pacific Female Health Market Size (2018-2029)
8.2 Asia-Pacific Female Health Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Female Health Market Size by Region (2018-2023)
8.4 Asia-Pacific Female Health Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia

9 LATIN AMERICA

9.1 Latin America Female Health Market Size (2018-2029)
9.2 Latin America Female Health Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Female Health Market Size by Country (2018-2023)
9.4 Latin America Female Health Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil

10 MIDDLE EAST & AFRICA

10.1 Middle East & Africa Female Health Market Size (2018-2029)
10.2 Middle East & Africa Female Health Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Female Health Market Size by Country (2018-2023)
10.4 Middle East & Africa Female Health Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE

11 KEY PLAYERS PROFILES

11.1 Veru Inc.
  11.1.1 Veru Inc. Company Detail
  11.1.2 Veru Inc. Business Overview
  11.1.3 Veru Inc. Female Health Introduction
  11.1.4 Veru Inc. Revenue in Female Health Business (2018-2023)
  11.1.5 Veru Inc. Recent Development
11.2 Allergan
  11.2.1 Allergan Company Detail
  11.2.2 Allergan Business Overview
  11.2.3 Allergan Female Health Introduction
  11.2.4 Allergan Revenue in Female Health Business (2018-2023)
  11.2.5 Allergan Recent Development
11.3 Bayer AG
  11.3.1 Bayer AG Company Detail
  11.3.2 Bayer AG Business Overview
  11.3.3 Bayer AG Female Health Introduction
  11.3.4 Bayer AG Revenue in Female Health Business (2018-2023)
  11.3.5 Bayer AG Recent Development
11.4 Merck
  11.4.1 Merck Company Detail
  11.4.2 Merck Business Overview
  11.4.3 Merck Female Health Introduction
  11.4.4 Merck Revenue in Female Health Business (2018-2023)
  11.4.5 Merck Recent Development
11.5 Pfizer
  11.5.1 Pfizer Company Detail
  11.5.2 Pfizer Business Overview
  11.5.3 Pfizer Female Health Introduction
  11.5.4 Pfizer Revenue in Female Health Business (2018-2023)
  11.5.5 Pfizer Recent Development
11.6 Teva Pharmaceuticals
  11.6.1 Teva Pharmaceuticals Company Detail
  11.6.2 Teva Pharmaceuticals Business Overview
  11.6.3 Teva Pharmaceuticals Female Health Introduction
  11.6.4 Teva Pharmaceuticals Revenue in Female Health Business (2018-2023)
  11.6.5 Teva Pharmaceuticals Recent Development
11.7 Agile Therapeutics
  11.7.1 Agile Therapeutics Company Detail
  11.7.2 Agile Therapeutics Business Overview
  11.7.3 Agile Therapeutics Female Health Introduction
  11.7.4 Agile Therapeutics Revenue in Female Health Business (2018-2023)
  11.7.5 Agile Therapeutics Recent Development
11.8 Amgen, Inc.
  11.8.1 Amgen, Inc. Company Detail
  11.8.2 Amgen, Inc. Business Overview
  11.8.3 Amgen, Inc. Female Health Introduction
  11.8.4 Amgen, Inc. Revenue in Female Health Business (2018-2023)
  11.8.5 Amgen, Inc. Recent Development
11.9 AstraZeneca
  11.9.1 AstraZeneca Company Detail
  11.9.2 AstraZeneca Business Overview
  11.9.3 AstraZeneca Female Health Introduction
  11.9.4 AstraZeneca Revenue in Female Health Business (2018-2023)
  11.9.5 AstraZeneca Recent Development
11.10 Bristol-Myers Squibb
  11.10.1 Bristol-Myers Squibb Company Detail
  11.10.2 Bristol-Myers Squibb Business Overview
  11.10.3 Bristol-Myers Squibb Female Health Introduction
  11.10.4 Bristol-Myers Squibb Revenue in Female Health Business (2018-2023)
  11.10.5 Bristol-Myers Squibb Recent Development

12 ANALYST'S VIEWPOINTS/CONCLUSIONS


13 APPENDIX

13.1 Research Methodology
  13.1.1 Methodology/Research Approach
  13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Global Female Health Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Medicines
Table 3. Key Players of Treatment
Table 4. Key Players of Other
Table 5. Global Female Health Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Female Health Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Female Health Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Female Health Market Share by Region (2018-2023)
Table 9. Global Female Health Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 10. Global Female Health Market Share by Region (2024-2029)
Table 11. Female Health Market Trends
Table 12. Female Health Market Drivers
Table 13. Female Health Market Challenges
Table 14. Female Health Market Restraints
Table 15. Global Female Health Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Female Health Market Share by Players (2018-2023)
Table 17. Global Top Female Health Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Female Health as of 2022)
Table 18. Ranking of Global Top Female Health Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by Female Health Revenue (CR5 and HHI) & (2018-2023)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Female Health Product Solution and Service
Table 22. Date of Enter into Female Health Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Female Health Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Female Health Revenue Market Share by Type (2018-2023)
Table 26. Global Female Health Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 27. Global Female Health Revenue Market Share by Type (2024-2029)
Table 28. Global Female Health Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Female Health Revenue Market Share by Application (2018-2023)
Table 30. Global Female Health Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 31. Global Female Health Revenue Market Share by Application (2024-2029)
Table 32. North America Female Health Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 33. North America Female Health Market Size by Country (2018-2023) & (US$ Million)
Table 34. North America Female Health Market Size by Country (2024-2029) & (US$ Million)
Table 35. Europe Female Health Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. Europe Female Health Market Size by Country (2018-2023) & (US$ Million)
Table 37. Europe Female Health Market Size by Country (2024-2029) & (US$ Million)
Table 38. Asia-Pacific Female Health Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 39. Asia-Pacific Female Health Market Size by Region (2018-2023) & (US$ Million)
Table 40. Asia-Pacific Female Health Market Size by Region (2024-2029) & (US$ Million)
Table 41. Latin America Female Health Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 42. Latin America Female Health Market Size by Country (2018-2023) & (US$ Million)
Table 43. Latin America Female Health Market Size by Country (2024-2029) & (US$ Million)
Table 44. Middle East & Africa Female Health Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 45. Middle East & Africa Female Health Market Size by Country (2018-2023) & (US$ Million)
Table 46. Middle East & Africa Female Health Market Size by Country (2024-2029) & (US$ Million)
Table 47. Veru Inc. Company Detail
Table 48. Veru Inc. Business Overview
Table 49. Veru Inc. Female Health Product
Table 50. Veru Inc. Revenue in Female Health Business (2018-2023) & (US$ Million)
Table 51. Veru Inc. Recent Development
Table 52. Allergan Company Detail
Table 53. Allergan Business Overview
Table 54. Allergan Female Health Product
Table 55. Allergan Revenue in Female Health Business (2018-2023) & (US$ Million)
Table 56. Allergan Recent Development
Table 57. Bayer AG Company Detail
Table 58. Bayer AG Business Overview
Table 59. Bayer AG Female Health Product
Table 60. Bayer AG Revenue in Female Health Business (2018-2023) & (US$ Million)
Table 61. Bayer AG Recent Development
Table 62. Merck Company Detail
Table 63. Merck Business Overview
Table 64. Merck Female Health Product
Table 65. Merck Revenue in Female Health Business (2018-2023) & (US$ Million)
Table 66. Merck Recent Development
Table 67. Pfizer Company Detail
Table 68. Pfizer Business Overview
Table 69. Pfizer Female Health Product
Table 70. Pfizer Revenue in Female Health Business (2018-2023) & (US$ Million)
Table 71. Pfizer Recent Development
Table 72. Teva Pharmaceuticals Company Detail
Table 73. Teva Pharmaceuticals Business Overview
Table 74. Teva Pharmaceuticals Female Health Product
Table 75. Teva Pharmaceuticals Revenue in Female Health Business (2018-2023) & (US$ Million)
Table 76. Teva Pharmaceuticals Recent Development
Table 77. Agile Therapeutics Company Detail
Table 78. Agile Therapeutics Business Overview
Table 79. Agile Therapeutics Female Health Product
Table 80. Agile Therapeutics Revenue in Female Health Business (2018-2023) & (US$ Million)
Table 81. Agile Therapeutics Recent Development
Table 82. Amgen, Inc. Company Detail
Table 83. Amgen, Inc. Business Overview
Table 84. Amgen, Inc. Female Health Product
Table 85. Amgen, Inc. Revenue in Female Health Business (2018-2023) & (US$ Million)
Table 86. Amgen, Inc. Recent Development
Table 87. AstraZeneca Company Detail
Table 88. AstraZeneca Business Overview
Table 89. AstraZeneca Female Health Product
Table 90. AstraZeneca Revenue in Female Health Business (2018-2023) & (US$ Million)
Table 91. AstraZeneca Recent Development
Table 92. Bristol-Myers Squibb Company Detail
Table 93. Bristol-Myers Squibb Business Overview
Table 94. Bristol-Myers Squibb Female Health Product
Table 95. Bristol-Myers Squibb Revenue in Female Health Business (2018-2023) & (US$ Million)
Table 96. Bristol-Myers Squibb Recent Development
Table 97. Research Programs/Design for This Report
Table 98. Key Data Information from Secondary Sources
Table 99. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Female Health Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Female Health Market Share by Type: 2022 VS 2029
Figure 3. Medicines Features
Figure 4. Treatment Features
Figure 5. Other Features
Figure 6. Global Female Health Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 7. Global Female Health Market Share by Application: 2022 VS 2029
Figure 8. Postmenopausal Osteoporosis Case Studies
Figure 9. Infertility Case Studies
Figure 10. Endometriosis Case Studies
Figure 11. PCOS Case Studies
Figure 12. Other Case Studies
Figure 13. Female Health Report Years Considered
Figure 14. Global Female Health Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 15. Global Female Health Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 16. Global Female Health Market Share by Region: 2022 VS 2029
Figure 17. Global Female Health Market Share by Players in 2022
Figure 18. Global Top Female Health Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Female Health as of 2022)
Figure 19. The Top 10 and 5 Players Market Share by Female Health Revenue in 2022
Figure 20. North America Female Health Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. North America Female Health Market Share by Country (2018-2029)
Figure 22. United States Female Health Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Canada Female Health Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Europe Female Health Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Europe Female Health Market Share by Country (2018-2029)
Figure 26. Germany Female Health Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. France Female Health Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. U.K. Female Health Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Italy Female Health Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Russia Female Health Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Nordic Countries Female Health Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Asia-Pacific Female Health Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Asia-Pacific Female Health Market Share by Region (2018-2029)
Figure 34. China Female Health Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Japan Female Health Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. South Korea Female Health Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Southeast Asia Female Health Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. India Female Health Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Australia Female Health Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Latin America Female Health Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Latin America Female Health Market Share by Country (2018-2029)
Figure 42. Mexico Female Health Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Brazil Female Health Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Middle East & Africa Female Health Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Middle East & Africa Female Health Market Share by Country (2018-2029)
Figure 46. Turkey Female Health Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Saudi Arabia Female Health Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Veru Inc. Revenue Growth Rate in Female Health Business (2018-2023)
Figure 49. Allergan Revenue Growth Rate in Female Health Business (2018-2023)
Figure 50. Bayer AG Revenue Growth Rate in Female Health Business (2018-2023)
Figure 51. Merck Revenue Growth Rate in Female Health Business (2018-2023)
Figure 52. Pfizer Revenue Growth Rate in Female Health Business (2018-2023)
Figure 53. Teva Pharmaceuticals Revenue Growth Rate in Female Health Business (2018-2023)
Figure 54. Agile Therapeutics Revenue Growth Rate in Female Health Business (2018-2023)
Figure 55. Amgen, Inc. Revenue Growth Rate in Female Health Business (2018-2023)
Figure 56. AstraZeneca Revenue Growth Rate in Female Health Business (2018-2023)
Figure 57. Bristol-Myers Squibb Revenue Growth Rate in Female Health Business (2018-2023)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed